Opportunity Information: Apply for PA 07 369

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Simian Models For The Oral Biology Of HIV Infection And AIDS Related Oral Complications (R21)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121 Oral Diseases and Disorders Research.
  • This funding opportunity was created on Dec 5, 2008 and posted on May 1, 2007.
  • Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Others (see text field entitled Additional Information on Eligibility for clarification) City or township governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Small businesses For profit organizations other than small businesses State governments Native American tribal governments (Federally recognized) Private institutions of higher education County governments Public housing authorities/Indian housing authorities.
  • Foreign institutions are eligible to apply.
Apply for PA 07 369

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The grant opportunity titled "Simian Models For The Oral Biology Of HIV Infection And AIDS Related Oral Complications (R21)" (Funding Opportunity Number PA-07-369) is an NIH discretionary grant aimed at supporting early-stage, exploratory research that uses nonhuman primate models, specifically simian macaques, to deepen understanding of how HIV infection affects the oral cavity and how AIDS-related oral complications develop. The central focus is oral biology in the context of HIV/AIDS, meaning applicants are expected to concentrate on oral tissues, oral immune responses, oral microbial ecology, mucosal pathology, and related mechanisms that drive oral disease in HIV-infected individuals. By emphasizing macaque models, the FOA is pushing for studies that can more closely mirror human HIV disease processes in ways that smaller animal models often cannot, especially for complex mucosal and immunologic interactions in the mouth.

This opportunity uses the NIH Exploratory/Developmental Research Grant (R21) mechanism. In practical terms, that signals that NIH is looking for projects that are innovative, hypothesis-generating, and potentially higher-risk than standard R01 work, but still grounded in a strong rationale and feasible experimental approach. The FOA also makes a point that funding is limited and that the intent is to maximize the use of animals that are already enrolled in ongoing studies. That detail matters because it nudges applicants toward designs that leverage existing cohorts, archived samples, or animals already being followed for related HIV/SIV studies, rather than proposing entirely new, resource-intensive primate studies. The theme is efficiency and added value: investigators should propose oral-biology questions that can be answered by building onto established primate research infrastructures.

Scientifically, the FOA invites a broad range of investigations so long as they advance knowledge of oral HIV/AIDS in simian macaque models. This includes basic biology (for example, how infection changes oral mucosal cell populations or barrier integrity), pathogenic mechanisms (how virus-host interactions and inflammation lead to oral lesions, periodontal changes, opportunistic infections, or salivary gland dysfunction), immunology (local mucosal immunity, antibody and T-cell dynamics in oral tissues, innate responses, cytokine networks), diagnosis (identifying oral biomarkers in saliva, gingival crevicular fluid, or mucosal biopsies that correlate with disease stages), treatment (testing interventions that reduce oral viral burden, inflammation, or secondary infections), and prevention (strategies that protect oral mucosa or reduce oral transmission-relevant factors). The common thread is translational relevance: even though the work is in macaques, the studies should clearly connect back to human oral complications of HIV/AIDS and how they might be better predicted, prevented, or managed.

Administrative details place the program within NIH and link it to the CFDA number 93.121 (Oral Diseases and Disorders Research), reinforcing that this is fundamentally an oral health-focused initiative rather than a general HIV pathogenesis call. There is no cost sharing or matching requirement, which means applicants are not expected to provide institutional or third-party matching funds as a condition of the award. The number of awards is not fixed; instead, NIH indicates that awards will depend on the number of applications received, their scientific quality, the proposed project durations, and budget requests. In other words, it is a competitive, merit-driven program with flexible award volume, typical of many NIH FOAs.

Eligibility is broad and includes many types of domestic U.S. organizations such as public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status), small businesses, for-profit entities (including those other than small businesses), and multiple levels of government entities (state, county, city/township), as well as eligible tribal governments and tribal organizations and certain public housing authorities. A notable point is that foreign institutions are also eligible to apply, which expands the applicant pool beyond U.S.-based organizations and can support international primate research settings where appropriate expertise and facilities exist.

The FOA was originally posted May 1, 2007, with multiple receipt dates (so applications were accepted on more than one due date rather than a single deadline), and it was later archived June 7, 2010. While the archived status means it is no longer an active current competition, the announcement still serves as a clear description of NIH priorities at that time: using macaque-based HIV/SIV research to answer unanswered questions about oral disease mechanisms and oral health complications associated with AIDS, while encouraging efficient use of existing primate resources. For full official requirements, application instructions, and any special review considerations that were in effect during the active period of the FOA, NIH directed applicants to the complete announcement page at http://grants.nih.gov/grants/guide/pa-files/PA-07-369.html and provided NIH Office of Extramural Research web support contacts for access or linking issues.

FAQs: Simian Models For The Oral Biology Of HIV Infection And AIDS Related Oral Complications (R21) (PA-07-369)

What is the goal of this grant opportunity?

This NIH discretionary funding opportunity supports early-stage, exploratory research using nonhuman primate models (specifically simian macaques) to improve understanding of how HIV infection affects the oral cavity and how AIDS-related oral complications develop.

What is the official title and funding opportunity number?

The opportunity is titled "Simian Models For The Oral Biology Of HIV Infection And AIDS Related Oral Complications (R21)" and the Funding Opportunity Number is PA-07-369.

What NIH grant mechanism does this use?

This opportunity uses the NIH Exploratory/Developmental Research Grant (R21) mechanism, which is intended for innovative, hypothesis-generating, and potentially higher-risk projects that are still supported by a strong rationale and a feasible approach.

What research models are emphasized?

The FOA emphasizes nonhuman primate models, specifically simian macaques, because they can more closely mirror human HIV disease processes than smaller animal models, particularly for complex mucosal and immunologic interactions in the mouth.

What is the scientific focus area?

The central focus is oral biology in the context of HIV/AIDS. Applications are expected to concentrate on topics such as oral tissues, oral immune responses, oral microbial ecology, mucosal pathology, and related mechanisms that drive oral disease in HIV-infected individuals.

What kinds of research topics are considered responsive?

The FOA invites a broad range of investigations as long as they advance knowledge of oral HIV/AIDS in simian macaque models. Examples include basic oral mucosal biology during infection, pathogenic mechanisms leading to oral lesions or periodontal changes, oral immunology, diagnostic biomarker development using oral fluids or tissues, and approaches related to treatment or prevention of oral complications.

Does the FOA allow both basic and translational research?

Yes. While the work is performed in macaques, the FOA emphasizes translational relevance and expects a clear connection to human oral complications of HIV/AIDS, including how these complications might be predicted, prevented, or managed.

Are studies of oral immune responses and mucosal pathology relevant?

Yes. The FOA specifically highlights oral immune responses, mucosal pathology, and related mechanisms, including antibody and T-cell dynamics in oral tissues, innate responses, and cytokine networks.

Are oral microbiology and microbial ecology in scope?

Yes. Oral microbial ecology is explicitly within the oral biology emphasis, particularly where it helps explain mechanisms of oral disease in the setting of HIV infection.

Are diagnostic biomarker studies in oral fluids or tissues included?

Yes. The FOA mentions identifying oral biomarkers in sources such as saliva, gingival crevicular fluid, or mucosal biopsies that correlate with disease stages.

Can applicants propose treatment-oriented or prevention-oriented studies?

Yes. The FOA includes treatment and prevention topics, such as testing interventions that reduce oral viral burden, inflammation, or secondary infections, and strategies that protect oral mucosa or reduce factors relevant to oral transmission.

Does the FOA encourage use of existing primate cohorts or samples?

Yes. The FOA notes limited funding and signals an intent to maximize the use of animals already enrolled in ongoing studies. This encourages leveraging established cohorts, archived samples, or animals already being followed for related HIV/SIV studies rather than proposing entirely new, resource-intensive primate studies.

Is this an oral health-focused opportunity or a general HIV pathogenesis call?

It is framed as an oral health-focused initiative. The FOA references CFDA 93.121 (Oral Diseases and Disorders Research), reinforcing the oral health and oral disease emphasis.

Is there a cost sharing or matching requirement?

No. The FOA states there is no cost sharing or matching requirement.

How many awards will be made?

The number of awards is not fixed. NIH indicates that awards depend on the number of applications received, scientific quality, proposed project durations, and budget requests.

Who is eligible to apply?

Eligibility is broad and includes many types of domestic U.S. organizations such as public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), small businesses, for-profit entities, state/county/city or township governments, eligible tribal governments and tribal organizations, and certain public housing authorities.

Are foreign institutions eligible to apply?

Yes. The FOA notes that foreign institutions are also eligible, allowing applications beyond U.S.-based organizations.

When was the FOA posted and what is its current status?

The FOA was originally posted on May 1, 2007, accepted applications on multiple receipt dates, and was later archived on June 7, 2010. Archived status means it is no longer an active current competition.

Were there multiple deadlines or a single deadline?

The FOA had multiple receipt dates, meaning applications were accepted on more than one due date rather than a single deadline.

Where can the full official announcement and instructions be found?

The FOA directed applicants to the complete announcement page at http://grants.nih.gov/grants/guide/pa-files/PA-07-369.html for official requirements, application instructions, and any special review considerations that were in effect during the active period.

Who was listed for help with web access or linking issues?

The FOA referenced NIH Office of Extramural Research web support contacts for access or linking issues related to the announcement page.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Implicating Noncoding RNAs in the Genetics of Mental Disorders (R01)

Previous opportunity: Medications Development for the Treatment of Cannabis Related Disorders (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 07 369

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 07 369) also looked into and applied for these:

Funding Opportunity
Implicating Noncoding RNAs in the Genetics of Mental Disorders (R01) Apply for PA 07 370

Funding Number: PA 07 370
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Implicating Noncoding RNAs in the Genetics of Mental Disorders (Collaborative R01) Apply for PA 07 371

Funding Number: PA 07 371
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Implicating Noncoding RNAs in the Genetics of Mental Disorders (R21) Apply for PA 07 372

Funding Number: PA 07 372
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Investigator Initiated Multi Site Clinical Trials (R01) Apply for PAR 07 373

Funding Number: PAR 07 373
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Harmonization of Longitudinal Cross National Surveys of Aging (R21) Apply for PAS 07 387

Funding Number: PAS 07 387
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Identifying and Reducing Diabetes and Obesity Related Health Disparities within Healthcare Systems (R01) Apply for PA 07 388

Funding Number: PA 07 388
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Biology of Manual Therapies (R01) Apply for PA 07 393

Funding Number: PA 07 393
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Outcomes in Children with Mild to Severe Hearing Loss (R01) Apply for PA 07 394

Funding Number: PA 07 394
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Transfusion Related Acute Lung Injury (TRALI) Basic Research (R01) Apply for PA 07 385

Funding Number: PA 07 385
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Young Children with Mild to Severe Hearing Loss (R01) Apply for PA 07 399

Funding Number: PA 07 399
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Young Children with Mild to Severe Hearing Loss (R21) Apply for PA 07 400

Funding Number: PA 07 400
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01) Apply for PA 07 406

Funding Number: PA 07 406
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21) Apply for PA 07 407

Funding Number: PA 07 407
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03) Apply for PA 07 408

Funding Number: PA 07 408
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Bridges to the Doctorate Program (R25) Apply for PAR 07 410

Funding Number: PAR 07 410
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Bridges to the Baccalaureate Program (R25) Apply for PAR 07 411

Funding Number: PAR 07 411
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCR Small Grant Program for New Investigators (R03) Apply for PAR 07 418

Funding Number: PAR 07 418
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R01) Apply for PA 07 427

Funding Number: PA 07 427
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R21) Apply for PA 07 428

Funding Number: PA 07 428
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R03) Apply for PA 07 429

Funding Number: PA 07 429
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 369", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.